Riskpilot← Back to searchSign inGet full accessENORM BioFactory A/S
A/SBankruptCVR 38847147Hedelundvej 15Raising of other animals · NACE 0148Est. 20178 employees
Revenue 2023
DKK -6,8M
+65% vs 2022
EBITDA margin
286.9%
-57% vs 2022
Equity ratio
26.4%
Financial strength
Net profit 2023
DKK -31,3M
-153% vs 2022
| Revenue | DKK -6,8M | +65% |
| EBITDA | DKK -19,5M | -57% |
| Net profit | DKK -31,3M | -153% |
| Total assets | DKK 493,8M | +55% |
| Equity | DKK 130,3M | -19% |
| Employees | 8 | — |
Legal name
ENORM BioFactory A/S
CVR number
38847147
Legal form
Aktieselskab
NACE code
0148 · Raising of other animals
Founded
3. august 2017
Share capital
DKK 700.000
Employees
8 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2023-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør sammen med to bestyrelsesmedlemmer i forening, eller af den samlede bestyrelse i forening.
Company purpose
Selskabets formål er at fremme brugen af insekter som foder og hermed forbundet aktivitet
Address
Hedelundvej 15
Phone
+4573709195
Email
info@enormbiofactory.com
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenue | — | — | -2.365 | -2.979 | -4.132 | -6.799 |
| Staff expenses | -0 | -0 | -1.396 | -2.601 | -8.262 | -12.705 |
| EBITDA | 939 | 2.154 | -3.761 | -5.987 | -12.394 | -19.504 |
| Depreciation & amort. | -0 | -0 | -17 | -821 | -2.543 | -2.531 |
| EBIT | 939 | 2.154 | -3.779 | -6.808 | -14.937 | -22.036 |
| Net financials | 0 | 0 | -22 | -257 | 424 | -18.090 |
| Profit before tax | 939 | 2.154 | -3.801 | -7.066 | -14.513 | -40.126 |
| Tax | -0 | -0 | -1.181 | -1.823 | -2.156 | -8.820 |
| Net profit | 939 | 2.154 | -2.620 | -5.243 | -12.357 | -31.306 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 26.969 | 48.879 | 318.804 | 493.845 |
| Equity | 939 | 3.092 | -5.530 | -10.773 | 161.562 | 130.257 |
| Long-term debt | 0 | 0 | 16.903 | 6.727 | 135.798 | 305.573 |
| Short-term debt | 0 | 0 | 15.596 | 52.924 | 21.444 | 58.015 |
| Total debt | 0 | 0 | 32.499 | 59.651 | 157.242 | 363.588 |
EBITDA margin
-1950417600.0%
This company
15.8%
Market median
-12344415290% vs market
20182023
Equity ratio
26.4%
This company
38.2%
Market median
-31% vs market
20182023
Return on equity
-24.0%
This company
18.4%
Market median
-230% vs market
20182023
Net profit margin
-3130570600.0%
This company
8.1%
Market median
-38649019853% vs market
20182023
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20182023
Debt / equity
2.79×
This company
0.62×
Market median
-350% vs market
20182023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-08-03 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JL Management | Management | 2022 | — | — |
CL Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
AH Management | Management | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ENORM Investor Holding A/S | Company | 100.0% | 100.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DANSK LANDBRUGS GROVVARESELSKAB A.M.B.A.ENORM Investor Holding A/S
ENORM BioFactory A/S (this company)Board members of ENORM BioFactory A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jane Lind Sam | Management | 0 companies |
| Carsten Lind Pedersen | Chief Executive Officer | 0 companies |
| Arne Holst Lauridsen | Management | 0 companies |
| Robert Jean Nicolas Didier lousberg | Chairman | 0 companies |
| Claus Olsen | Board of Directors | 0 companies |
| Troels Møller Olesen | Board of Directors | 0 companies |
| Christoffer Hage | Chairman | 0 companies |
| Thomas Hjort Winther | Board of Directors | 0 companies |
| Peter Agentoft Nielsen | Chairman | 0 companies |
| Bernhard Johannes Meerpohl | Board of Directors | 0 companies |
| Jens Havskov Thorsen | Board of Directors | 0 companies |
| Lasse Kirketerp Hinrichsen | Board of Directors | 0 companies |